Global and China Gaprin Market Insights, Forecast to 2027

Gaprin is a full-fledged microbiological protein, which is a biomass of inactivated cells of non-pathogenic methanotrophic bacteria and is intended for use as the main functional component of compound feeds and protein-vitamin supplements (BVD). Thanks to it, it is possible to produce complete, balanced compound feeds that ensure the intensive development of animal husbandry, poultry and fish farming. Gaprin contains: crude protein 70-79%. According to its composition, gaprin is a complete protein product with a high content of B vitamins (especially B12), amino acids and microelements, which fully meets the needs of animals of various groups and ages. In addition, in comparison with protein feeds of plant origin (including cereals and legumes, including soybeans), gaprin provides balanced amino acid nutrition for animals, primarily in terms of lysine, serine and methionine. Gaprin was produced from 1985 to 1994 at a pilot plant at the Svetlo-Yarsk BVK plant in the Volgograd region of CIS. Of the 40 thousand tons of haprin produced during the specified period, most of it was exported. However, in 1994 this production was closed. The bioprotein gaprin can also be produced from associated petroleum gas (APG), which is still flared in refineries and oil fields, including offshore oil platforms, as well as from methane from mines, coal seams and from methane biogas from waste processing.
Global Gaprin key players include Unibio, Calysta, Prtotelux, Metanica, Giprobiosyntez, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe and North America, both have a share about 38% percent. In terms of product, Feed Grade Gaprin is the largest segment, with a share over 70%. And in terms of Application, the largest level is Animal Feed, followed by Food & Beverages, etc.

Market Analysis and Insights: Global and China Gaprin Market
This report focuses on global and China Gaprin market.
In 2020, the global Gaprin market size was US$ 134 million and it is expected to reach US$ 4745.4 million by the end of 2027, with a CAGR of 60.3% during 2021-2027. In China the Gaprin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Gaprin Scope and Market Size
Gaprin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gaprin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Gaprin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Food Grade Gaprin
Feed Grade Gaprin

Segment by Application
Food & Beverages
Animal Feed
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Unibio
Calysta
Prtotelux
Metanica
Giprobiosyntez

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-18848304

02-Aug-2021

136
License